Insider Buying Sparks Debate Over Nektar Therapeutics’ Future Direction, Amid Market Sell‑Off and Pipeline Uncertainty
Insider buying at Nektar Therapeutics signals cautious optimism—discover how recent trades and pipeline milestones could shape the stock’s next move.
4 minutes to read